| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mallinckrodt plc | Director | Ordinary Shares | 787 | $68,076 | $86.50 | 31 Jul 2025 | Direct |
| Mereo BioPharma Group plc | Director | Share Options (Right to buy) | 55,000 | $55,550 | $1.01 | 05 Feb 2025 | Direct |
| Mereo BioPharma Group plc | Director | Deferred Restricted Stock Units | 13,719 | 05 Feb 2025 | Direct | ||
| Mallinckrodt plc | Director | Restricted Stock Units | 5,416 | 20 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465925100948-yoskowitz-marc-j-2025-10-20 | Mallinckrodt plc | 20 Oct 2025 | 1 | $0 | 4 | Director | 20 Oct 2025, 20:01 |
| /report/000110465925079949-yoskowitz-marc-j-2025-08-14 | Mallinckrodt plc | 14 Aug 2025 | 1 | $0 | 4 | Director | 18 Aug 2025, 21:06 |
| /report/000110465925073781-yoskowitz-marc-j-2025-07-31 | Mallinckrodt plc | 31 Jul 2025 | 0 | $0 | 3 | Director | 04 Aug 2025, 20:46 |
| MREO | Mereo BioPharma Group plc | 05 Feb 2025 | 2 | $0 | 4 | Director | 06 Feb 2025, 16:30 |
| MREO | Mereo BioPharma Group plc | 08 Feb 2024 | 2 | $0 | 4 | Director | 09 Feb 2024, 16:15 |
| MREO | Mereo Biopharma Group plc | 01 Jan 2024 | 0 | $0 | 3 | Director | 02 Jan 2024, 16:15 |